Search

Your search keyword '"Xu, Rui‐Hua"' showing total 1,622 results
Start Over Author "Xu, Rui‐Hua"
1,622 results on '"Xu, Rui‐Hua"'

103. Publisher Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial

Author

Mai, Hai-Qiang, Chen, Qiu-Yan, Chen, Dongping, Hu, Chaosu, Yang, Kunyu, Wen, Jiyu, Li, Jingao, Shi, Ying-Rui, Jin, Feng, Xu, Ruilian, Pan, Jianji, Qu, Shenhong, Li, Ping, Hu, Chunhong, Liu, Yi-Chun, Jiang, Yi, He, Xia, Wang, Hung-Ming, Lim, Wan-Teck, Liao, Wangjun, He, Xiaohui, Chen, Xiaozhong, Liu, Zhigang, Yuan, Xianglin, Li, Qi, Lin, Xiaoyan, Jing, Shanghua, Chen, Yanju, Lu, Yin, Hsieh, Ching-Yun, Yang, Muh-Hwa, Yen, Chia-Jui, Samol, Jens, Feng, Hui, Yao, Sheng, Keegan, Patricia, and Xu, Rui-Hua

Published
2022
Full Text
View/download PDF

105. Clinicopathological characteristics and postoperative prognosis of patients with nuclear pedigree of esophageal squamous cell carcinoma

Author

Wei, Meng Xia, primary, Song, Xin, additional, Zhao, Xue Ke, additional, Han, Wen Li, additional, Bao, Qi De, additional, Han, Xue Nan, additional, Xu, Rui Hua, additional, Li, Xin Min, additional, Fan, Zong Min, additional, Wang, Ran, additional, Li, Xing Song, additional, Hu, Jing Feng, additional, Li, Jia, additional, Li, Bei, additional, Tan, Hui Fang, additional, Gao, She Gan, additional, Zhou, Fu You, additional, and Wang, Li Dong, additional

Published
2023
Full Text
View/download PDF

106. TROPION-PanTumor03: Phase 2, multicenter study of datopotamab deruxtecan (Dato-DXd) as monotherapy and in combination with anticancer agents in patients (pts) with advanced/metastatic solid tumors.

Author

Janjigian, Yelena Y., primary, Oaknin, Ana, additional, Lang, Joshua Michael, additional, Ciombor, Kristen Keon, additional, Ray-Coquard, Isabelle Laure, additional, Oza, Amit M., additional, Yonemori, Kan, additional, Xu, Rui-Hua, additional, Zhao, Jimmy, additional, Gajavelli, Srikanth, additional, Filant, Justyna, additional, Hovey, Tina, additional, and Meric-Bernstam, Funda, additional

Published
2023
Full Text
View/download PDF

112. Retraction Note: A positive feedback loop consisting of C12orf59/NF-κB/CDH11 promotes gastric cancer invasion and metastasis

Author

Zhang Jia-Xing, He Wei-Ling, Feng Zi-Hao, Chen Dong-Liang, Gao Ying, He Ying, Qin Kai, Zheng Zhou-San, Chen Cui, Weng Hui-Wen, Yun Miao, Ye Sheng, Xu Rui-Hua, and Xie Dan

Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13046-019-1114-2.

Published
2021
Full Text
View/download PDF

118. Pan‐cancer landscape of tumour endothelial cells pinpoints insulin receptor as a novel antiangiogenic target and predicts immunotherapy response.

Author

Zheng, Yongqiang, Pan, Yi‐Qian, Liao, Kun, Yu, Kai, Wu, Qinian, Chen, Yanxing, Deng, Yuqing, Sun, Hui, Pu, Hengying, Ju, Huai‐Qiang, Xu, Rui‐Hua, and Liu, Ze‐Xian

Subjects
INSULIN receptors, ENDOTHELIAL cells, NEOVASCULARIZATION inhibitors, IMMUNOTHERAPY, TUMORS
Abstract

This article presents a study on tumour endothelial cells (TECs) and their role in tumour development and angiogenesis. The researchers created a pan-cancer TEC atlas using single-cell sequencing data from 381 samples. They identified different clusters of TECs and found that angiogenic components were elevated in tumours compared to normal endothelial cells. They also discovered two novel tip EC clusters, INSR+ tip ECs and PGF+ tip ECs, which were associated with angiogenesis. The study provides valuable insights into the mechanisms of tumour angiogenesis and suggests potential antiangiogenic targets for future therapies. Additionally, the article discusses the role of the insulin receptor (INSR) in angiogenesis, specifically in tumor endothelial cells (TECs). The study found that INSR is expressed exclusively in tumor ECs and is correlated with classical EC markers in multiple cancers, indicating its role as an angiogenic marker. In vitro and in vivo experiments demonstrated that INSR enhances angiogenic capacity, making it a promising antiangiogenic target. Furthermore, the study found that mature venous ECs expressing MHC-II molecules are associated with a better response to immunotherapy. The findings contribute to the development of innovative antiangiogenic agents. [Extracted from the article]

Published
2023
Full Text
View/download PDF

121. Supplementary Figures from The Macrophage-Associated LncRNA MALR Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer

Author

Liu, Jia, primary, Liu, Ze-Xian, primary, Li, Jia-Jun, primary, Zeng, Zhao-Lei, primary, Wang, Jin-Hong, primary, Luo, Xiao-Jing, primary, Wong, Chau-Wei, primary, Zheng, Jia-Bo, primary, Pu, Heng-Ying, primary, Mo, Hai-Yu, primary, Sheng, Hui, primary, Wu, Qi-Nian, primary, Li, Hao, primary, Wan, Gang, primary, Li, Bo, primary, Wang, De-shen, primary, Xu, Rui-Hua, primary, and Ju, Huai-Qiang, primary

Published
2023
Full Text
View/download PDF

122. Supplementary Table 1 from The Macrophage-Associated LncRNA MALR Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer

Author

Liu, Jia, primary, Liu, Ze-Xian, primary, Li, Jia-Jun, primary, Zeng, Zhao-Lei, primary, Wang, Jin-Hong, primary, Luo, Xiao-Jing, primary, Wong, Chau-Wei, primary, Zheng, Jia-Bo, primary, Pu, Heng-Ying, primary, Mo, Hai-Yu, primary, Sheng, Hui, primary, Wu, Qi-Nian, primary, Li, Hao, primary, Wan, Gang, primary, Li, Bo, primary, Wang, De-shen, primary, Xu, Rui-Hua, primary, and Ju, Huai-Qiang, primary

Published
2023
Full Text
View/download PDF

123. Supplementary Table 3 from The Macrophage-Associated LncRNA MALR Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer

Author

Liu, Jia, primary, Liu, Ze-Xian, primary, Li, Jia-Jun, primary, Zeng, Zhao-Lei, primary, Wang, Jin-Hong, primary, Luo, Xiao-Jing, primary, Wong, Chau-Wei, primary, Zheng, Jia-Bo, primary, Pu, Heng-Ying, primary, Mo, Hai-Yu, primary, Sheng, Hui, primary, Wu, Qi-Nian, primary, Li, Hao, primary, Wan, Gang, primary, Li, Bo, primary, Wang, De-shen, primary, Xu, Rui-Hua, primary, and Ju, Huai-Qiang, primary

Published
2023
Full Text
View/download PDF

124. Data from The Macrophage-Associated LncRNA MALR Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer

Author

Liu, Jia, primary, Liu, Ze-Xian, primary, Li, Jia-Jun, primary, Zeng, Zhao-Lei, primary, Wang, Jin-Hong, primary, Luo, Xiao-Jing, primary, Wong, Chau-Wei, primary, Zheng, Jia-Bo, primary, Pu, Heng-Ying, primary, Mo, Hai-Yu, primary, Sheng, Hui, primary, Wu, Qi-Nian, primary, Li, Hao, primary, Wan, Gang, primary, Li, Bo, primary, Wang, De-shen, primary, Xu, Rui-Hua, primary, and Ju, Huai-Qiang, primary

Published
2023
Full Text
View/download PDF

125. Supplementary Movie 1 from The Macrophage-Associated LncRNA MALR Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer

Author

Liu, Jia, primary, Liu, Ze-Xian, primary, Li, Jia-Jun, primary, Zeng, Zhao-Lei, primary, Wang, Jin-Hong, primary, Luo, Xiao-Jing, primary, Wong, Chau-Wei, primary, Zheng, Jia-Bo, primary, Pu, Heng-Ying, primary, Mo, Hai-Yu, primary, Sheng, Hui, primary, Wu, Qi-Nian, primary, Li, Hao, primary, Wan, Gang, primary, Li, Bo, primary, Wang, De-shen, primary, Xu, Rui-Hua, primary, and Ju, Huai-Qiang, primary

Published
2023
Full Text
View/download PDF

126. Supplementary Table 2 from The Macrophage-Associated LncRNA MALR Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer

Author

Liu, Jia, primary, Liu, Ze-Xian, primary, Li, Jia-Jun, primary, Zeng, Zhao-Lei, primary, Wang, Jin-Hong, primary, Luo, Xiao-Jing, primary, Wong, Chau-Wei, primary, Zheng, Jia-Bo, primary, Pu, Heng-Ying, primary, Mo, Hai-Yu, primary, Sheng, Hui, primary, Wu, Qi-Nian, primary, Li, Hao, primary, Wan, Gang, primary, Li, Bo, primary, Wang, De-shen, primary, Xu, Rui-Hua, primary, and Ju, Huai-Qiang, primary

Published
2023
Full Text
View/download PDF

127. Supplementary Methods from The Macrophage-Associated LncRNA MALR Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer

Author

Liu, Jia, primary, Liu, Ze-Xian, primary, Li, Jia-Jun, primary, Zeng, Zhao-Lei, primary, Wang, Jin-Hong, primary, Luo, Xiao-Jing, primary, Wong, Chau-Wei, primary, Zheng, Jia-Bo, primary, Pu, Heng-Ying, primary, Mo, Hai-Yu, primary, Sheng, Hui, primary, Wu, Qi-Nian, primary, Li, Hao, primary, Wan, Gang, primary, Li, Bo, primary, Wang, De-shen, primary, Xu, Rui-Hua, primary, and Ju, Huai-Qiang, primary

Published
2023
Full Text
View/download PDF

131. Supplementary Data from Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Author

Shah, Manish A., primary, Shitara, Kohei, primary, Lordick, Florian, primary, Bang, Yung-Jue, primary, Tebbutt, Niall C., primary, Metges, Jean-Phillippe, primary, Muro, Kei, primary, Lee, Keun-Wook, primary, Shen, Lin, primary, Tjulandin, Sergei, primary, Hays, John L., primary, Starling, Naureen, primary, Xu, Rui-Hua, primary, Sturtz, Keren, primary, Fontaine, Marilyn, primary, Oh, Cindy, primary, Brooks, Emily M., primary, Xu, Bo, primary, Li, Wei, primary, Li, Chiang J., primary, Borodyansky, Laura, primary, and Van Cutsem, Eric, primary

Published
2023
Full Text
View/download PDF

133. Supplementary Table from Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Author

Shah, Manish A., primary, Shitara, Kohei, primary, Lordick, Florian, primary, Bang, Yung-Jue, primary, Tebbutt, Niall C., primary, Metges, Jean-Phillippe, primary, Muro, Kei, primary, Lee, Keun-Wook, primary, Shen, Lin, primary, Tjulandin, Sergei, primary, Hays, John L., primary, Starling, Naureen, primary, Xu, Rui-Hua, primary, Sturtz, Keren, primary, Fontaine, Marilyn, primary, Oh, Cindy, primary, Brooks, Emily M., primary, Xu, Bo, primary, Li, Wei, primary, Li, Chiang J., primary, Borodyansky, Laura, primary, and Van Cutsem, Eric, primary

Published
2023
Full Text
View/download PDF

136. Supplementary Figure from Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Author

Shah, Manish A., primary, Shitara, Kohei, primary, Lordick, Florian, primary, Bang, Yung-Jue, primary, Tebbutt, Niall C., primary, Metges, Jean-Phillippe, primary, Muro, Kei, primary, Lee, Keun-Wook, primary, Shen, Lin, primary, Tjulandin, Sergei, primary, Hays, John L., primary, Starling, Naureen, primary, Xu, Rui-Hua, primary, Sturtz, Keren, primary, Fontaine, Marilyn, primary, Oh, Cindy, primary, Brooks, Emily M., primary, Xu, Bo, primary, Li, Wei, primary, Li, Chiang J., primary, Borodyansky, Laura, primary, and Van Cutsem, Eric, primary

Published
2023
Full Text
View/download PDF

140. Supplementary Figures and Materials and Methods from A Feedback Circuitry between Polycomb Signaling and Fructose-1, 6-Bisphosphatase Enables Hepatic and Renal Tumorigenesis

Author

Liao, Kun, primary, Deng, Shuye, primary, Xu, Liyan, primary, Pan, Wenfeng, primary, Yang, Shiyu, primary, Zheng, Fufu, primary, Wu, Xingui, primary, Hu, Hongrong, primary, Liu, Zhijun, primary, Luo, Junhang, primary, Zhang, Rui, primary, Kuang, Dong-Ming, primary, Dong, Jiajun, primary, Wu, Yi, primary, Zhang, Hui, primary, Zhou, Penghui, primary, Bei, Jin-Xin, primary, Xu, Yang, primary, Ji, Yin, primary, Wang, Peng, primary, Ju, Huai-Qiang, primary, Xu, Rui-Hua, primary, and Li, Bo, primary

Published
2023
Full Text
View/download PDF

145. Supplementary Tables from A Feedback Circuitry between Polycomb Signaling and Fructose-1, 6-Bisphosphatase Enables Hepatic and Renal Tumorigenesis

Author

Liao, Kun, primary, Deng, Shuye, primary, Xu, Liyan, primary, Pan, Wenfeng, primary, Yang, Shiyu, primary, Zheng, Fufu, primary, Wu, Xingui, primary, Hu, Hongrong, primary, Liu, Zhijun, primary, Luo, Junhang, primary, Zhang, Rui, primary, Kuang, Dong-Ming, primary, Dong, Jiajun, primary, Wu, Yi, primary, Zhang, Hui, primary, Zhou, Penghui, primary, Bei, Jin-Xin, primary, Xu, Yang, primary, Ji, Yin, primary, Wang, Peng, primary, Ju, Huai-Qiang, primary, Xu, Rui-Hua, primary, and Li, Bo, primary

Published
2023
Full Text
View/download PDF

147. Clinical Benefit of First-Line Programmed Death-1 Antibody Plus Chemotherapy in Low Programmed Cell Death Ligand 1–Expressing Esophageal Squamous Cell Carcinoma: A Post Hoc Analysis of JUPITER-06 and Meta-Analysis

Author

Wu, Hao-Xiang, primary, Pan, Yi-Qian, additional, He, Ye, additional, Wang, Zi-Xian, additional, Guan, Wen-Long, additional, Chen, Yan-Xing, additional, Yao, Yi-Chen, additional, Shao, Ning-Yi, additional, Xu, Rui-Hua, additional, and Wang, Feng, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results